Ono Pharmaceutical Co. Ltd. | Income Statement
Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
143,247
135,775
160,284
244,797
261,836
288,634
Cost of Goods Sold (COGS) incl. D&A
34,227
36,534
42,875
66,913
67,093
85,862
Gross Income
109,020
99,241
117,409
177,884
194,743
202,772
SG&A Expense
81,309
82,170
85,997
118,166
135,174
138,008
EBIT
-
15,355
30,014
59,718
59,569
64,764
Unusual Expense
26
430
19
14,264
25
1,524
Non Operating Income/Expense
2,645
3,007
3,282
1,007
4,314
1,858
Interest Expense
14
31
225
40
21
46
Pretax Income
29,460
18,292
33,304
74,540
63,922
65,141
Income Tax
8,922
5,089
8,080
18,504
13,525
13,462
Equity in Affiliates
4
13
32
-
-
-
Consolidated Net Income
20,542
13,216
25,192
56,036
50,397
51,679
Net Income
20,344
12,976
24,979
55,793
50,284
51,539
Net Income After Extraordinaries
20,344
12,976
24,979
55,793
50,284
51,539
Net Income Available to Common
20,344
12,976
24,979
55,793
50,284
51,539
EPS (Basic)
38.38
24.48
47.13
105.27
97.00
100.25
Basic Shares Outstanding
530
530
530
530
518
514
EPS (Diluted)
38.38
24.48
47.13
105.26
96.99
100.24
Diluted Shares Outstanding
530
530
530
530
518
514
EBITDA
31,374
21,455
36,548
67,539
68,782
75,385
Other Operating Expense
1,446
1,716
1,398
-
-
-
Non-Operating Interest Income
538
391
252
133
89
92
Minority Interest Expense
198
240
213
243
113
140
Equity in Affiliates (Pretax)
-
-
-
541
4
1
About Ono Pharmaceutical Co.
View Profile
